Connection

DAVID LONARD to Autoantigens

This is a "connection" page, showing publications DAVID LONARD has written about Autoantigens.
Connection Strength

0.451
  1. The REG? inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells. Nat Commun. 2020 08 06; 11(1):3904.
    View in: PubMed
    Score: 0.163
  2. REGgamma modulates p53 activity by regulating its cellular localization. J Cell Sci. 2010 Dec 01; 123(Pt 23):4076-84.
    View in: PubMed
    Score: 0.083
  3. Comparative analysis of REG{gamma} expression in mouse and human tissues. J Mol Cell Biol. 2010 Aug; 2(4):192-8.
    View in: PubMed
    Score: 0.080
  4. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway. Mol Cell. 2007 Jun 22; 26(6):831-42.
    View in: PubMed
    Score: 0.066
  5. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome. Cell. 2006 Jan 27; 124(2):381-92.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.